Durvalumab is used in the treatment of non-small cell lung cancer, liver cancer, endometrial cancer, and biliary tract cancer.
Common side effects of Durvalumab include nasopharyngitis (inflammation of the throat and nasal passages), upper respiratory tract infection, and rash.
Durvalumab 120mg

₹42,656.2
Durvalumab 500mg

₹189,585